Plunkett Research Online: Aerpio Pharmaceuticals Inc

AERPIO PHARMACEUTICALS INC (ARPO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product AKB-9778, is a Tie2 activator being developed for the treatment of diabetic eye disease. Other products under the pipeline are cc-1536 and c-4924......



Aerpio Pharmaceuticals Inc
Ticker: ARPO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 513 985-1920
Fax: 513 985-0999
Address: 9987 Carver Road
Cincinnati, OH 45242 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description

Stephen Hoffman CEO/Director
Michael Rogers CFO/Chief Accounting Officer/Other Corporate Officer
See More
Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product AKB-9778, is a Tie2 activator being developed for the treatment of diabetic eye disease. Other products under the pipeline are cc-1536 and c-4924......See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: